NOV 13, 2019 09:31 AM PST

Sherlock's DNA biosensors set to make diagnostics elementary

Waiting anxiously to receive results from expensive diagnostic laboratory tests could soon be a thing of the past thanks to a technological breakthrough. Engineering start-up Sherlock Biosciences, in collaboration with UK diagnostics company Mologic, recently announced they are joining forces to develop sophisticated molecular diagnostic devices simple enough for anyone to use - all from the comfort of home.

Backed by funding from the Bill & Melinda Gates Foundation, this new venture aims to blend Sherlock’s proprietary synthetic biology-based platform with Mologic’s lateral flow immunoassays. The result? Easy-to-use diagnostic devices, completely bypassing the need for complicated instrumentation and expert technicians.

Lateral flow technology is already widely used for point-of-care testing, with the most common example being pregnancy test sticks. Biological samples applied to the device get drawn up through a membrane and flow over antibodies. Interactions between the sensor and a biological marker present in the sample trigger a color change that acts as a visual cue, indicating a positive or negative result. 

The difference with Mologic’s platform is that it’s exceptionally sensitive, low-cost, has a clear visual readout and can potentially be applied to many infectious diseases, for which diagnosis is at present, a complicated affair.

The strategy of this collaboration is to amplify these diagnostic capabilities by coupling them with INSPECTR™, Sherlock’s synthetic DNA biosensor platform. INSPECTR™ (an acronym for Internal Splint-Pairing Expression Cassette Translation Reaction) is the result of research performed by Sherlock’s co-founders at Harvard University. Biosensors in INSPECTR™ can detect minute amounts of a target nucleic acid sequence in blood, saliva or urine. This drives the production of a reporter protein, which can be tailored to create a signature visual signal - a colored indicator or a fluorescent glow, for example.

Speaking on the significance of this development, co-founder, CEO and President of Sherlock, Rahul K. Dhanda said, “This program will enable us to build on the power of our INSPECTR platform to create diagnostic tools that provide accurate and affordable results in virtually any setting, while working with Mologic and the Bill & Melinda Gates Foundation to develop lateral flow technology to improve global health.”

Sources: Technology Networks, Sherlock Biosciences

About the Author
  • Tara Fernandez is a Cell Biologist who works on commercializing new technology in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies and nanotechnologies. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
NOV 21, 2019
Cancer
NOV 21, 2019
What can we do about the financial hardships of cancer?
Have you ever had the unfortune of getting out of the hospital and later receiving a medical bill for which you were completely unprepared? Even if you hav...
NOV 21, 2019
Genetics & Genomics
NOV 21, 2019
Membrane-less Organelle Found to Play a Role in Preventing Cancer
In recent years, scientists have found that a phenomenon called phase separation plays a critical role in the functions of cells....
NOV 21, 2019
Cardiology
NOV 21, 2019
Protein Build-Up Places Heart at Risk
Amyloidosis is a disease caused by protein buildup in the body. These abnormal proteins, called amyloids, are produced in the bone marrow. Multiple types o...
NOV 21, 2019
Clinical & Molecular DX
NOV 21, 2019
Forecasting Chronic Pain
Chronic pain comes in many forms. Over half of those suffering from chronic pain, say they experience life-altering levels of pain on a daily basis. Many s...
NOV 21, 2019
Clinical & Molecular DX
NOV 21, 2019
Opioid Addiction Can be Controlled Using an In-Brain Chip Technology: First U.S. Clinical Trial
Opioid addiction is a long-lasting (chronic) disease that can cause major health, social, and economic problems. Opioids are a class of drugs that act...
NOV 21, 2019
Cell & Molecular Biology
NOV 21, 2019
Scientists Reveal a Link Between Brain Fog and Inflammation
When people get sick, they often also feel tired, which can be as troublesome as their disease....
Loading Comments...